戻る
Aspen Pharmacare Holdings Limited (APNHY)価格
APNHY 株価推移チャート
APNHY 収入
Aspen Pharmacare Holdings Limited
$6.74
0%
$0
終値： Feb 06, 16:00:00 GMT-5
$6.74
0%
$0
アフターマーケット：Feb 06, 20:00:00 GMT-5
最新の利益結果: Q4 '23
報告済み: 2023-08-30
歴史的収益
四半期
年次
EPS
収入
Earnings FAQ
APNHYの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Aspen Pharmacare Holdings Limited APNHYの前四半期の収益はどうでしたか？
Aspen Pharmacare Holdings Limitedの収益見積もりはいくらですか？
Aspen Pharmacare Holdings Limitedの収益品質スコアはどれくらいですか？
Aspen Pharmacare Holdings Limitedはいつ収益を報告しますか？
Aspen Pharmacare Holdings Limitedの予想収益はいくらですか？
Aspen Pharmacare Holdings Limitedは収益予想を上回りましたか？
主要データ
前終値
$6.74
始値
$7.4
当日レンジ
$6.74 - $7.4
52週レンジ
$5.24 - $10.14
取引高
3.6K
平均取引高
1.1K
1株当たり利益(TTM)
-0.15
配当利回り
--
時価総額
$2.9B
Aspen Pharmacare Holdings plcとは何ですか？
Aspen Pharmacare Holdings Ltd. manufactures and supplies branded and generic pharmaceutical products. The company is headquartered in La Lucia, Kwazulu-Natal and currently employs 9,128 full-time employees. The firm focuses on marketing and manufacturing a range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets. Its segments include Prescription, Over the counter (OTC), Injectables, Active Pharmaceutical Ingredients (API), Finished Dose Form (FDF) and Heparin. The company offers sterile products in injectable form primarily administered in hospitals and also those prescribed and administered by either physicians or in a retail pharmacy environment. Its key brands include Arixtra, Diprivan, Fraxiparine, Marcaine, Sustanon and Xylocaine (Injectables). Its OTC segment includes products that do not require prescriptions and are primarily sold in the retail pharmacy and fast-moving consumer goods sectors. Its Prescription segment includes products which generally require a prescription from a healthcare professional.